TrialAmerican journal of hematology2016

Dasatinib in imatinib-resistant or -intolerant chronic-phase, chronic myeloid leukemia patients: 7-year follow-up of study CA180-034.

Neil P Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.